Ryan Irvine Pyng Medical Corp. PYT-X HOLD Aug 20, 2008

Has had a bit of a problem in producing steady quarter over quarter earnings. 1 to 2 years out the company has good solid potential. Good technology.

Ryan Irvine

Unlock Rating

$0.410

Stock price when the opinion was issued

biotechnology pharmaceutical

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

HOLD

Have a technology that delivers vital fluids to a patient in an emergency situation. Tremendous growth in earnings last year, up to about 4 1/2 cents per share. Has some lumpiness in its earnings traditionally. Good growth profile 1 to 2 years out.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Ryan Irvine Pyng Medical Corp. PYT-X HOLD Aug 20, 2008

You might be interested:

Pyng Medical Corp.(PYT-X)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals

Most Recent Experts

Bruce Murray

The Panic-Proof Portfolio (Stockchase Research)

The Weekly Buzzing Stocks by Billy Kawasaki

Chris Blumas

Stockchase Insights